This is the authors' abstract. We don't add key points for this paper.
In this issue of Blood, Xu-Monette et al show that CD37 protein expression is a strong prognostic marker in diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP.1 CD37 negativity is associated with poor outcome and a high prevalence of adverse genetic and biologic features.1
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bertoni et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: